Literature DB >> 8247525

Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.

K Bousset1, M Henriksson, J M Lüscher-Firzlaff, D W Litchfield, B Lüscher.   

Abstract

Myc proteins have been implicated in the regulation of cell growth and differentiation. The identification of Max, a basic region/helix-loop-helix/leucine zipper protein, as a partner for Myc has provided insights into Myc's molecular function as a transcription factor. Recent evidence indicates that the relative abundance of Myc and Max is important to determine the level of specific gene transcription. In this report we have identified two major in vivo phosphorylation sites in Max (Ser-2 and -11) which can be modified in vitro by casein kinase II (CKII). Phosphorylation of these sites modulates DNA-binding by increasing both the on- and off-rates of Max homo- as well as Myc/Max heterodimers. In addition, our data indicate that the steady state binding of the shorter version of Max (p21) to DNA was similar yet its rate of dissociation faster than that of longer version of Max (p22). These data argue that different Max complexes have different kinetic properties and that these can be modified by CKII phosphorylation. We propose this as an important biological mechanism by which different dimeric complexes can exchange with varying efficiencies on DNA, thereby responding to changes in cell growth conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8247525

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Mad1 function is regulated through elements within the carboxy terminus.

Authors:  G Barrera-Hernandez; C M Cultraro; S Pianetti; S Segal
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

3.  Expression, purification and characterisation of a novel mutant of the human protein kinase CK2.

Authors:  Elena Grasselli; Graziano Noviello; Cristina Rando; Claudio Nicolini; Laura Vergani
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

4.  Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation.

Authors:  S E Johnson; X Wang; S Hardy; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 5.  Proteins in unexpected locations.

Authors:  N R Smalheiser
Journal:  Mol Biol Cell       Date:  1996-07       Impact factor: 4.138

6.  Max is acetylated by p300 at several nuclear localization residues.

Authors:  Francesco Faiola; Yi-Ting Wu; Songqin Pan; Kangling Zhang; Anthony Farina; Ernest Martinez
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

7.  Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy.

Authors:  Uros Kuzmanov; Hongbo Guo; Diana Buchsbaum; Jake Cosme; Cynthia Abbasi; Ruth Isserlin; Parveen Sharma; Anthony O Gramolini; Andrew Emili
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-14       Impact factor: 11.205

8.  Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor.

Authors:  Volker Ellenrieder; Jin-San Zhang; Joanna Kaczynski; Raul Urrutia
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

9.  Initiation binding repressor, a factor that binds to the transcription initiation site of the histone h5 gene, is a glycosylated member of a family of cell growth regulators [corrected].

Authors:  A Gómez-Cuadrado; M Martín; M Noël; A Ruiz-Carrillo
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

10.  Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.

Authors:  M Arsura; A Deshpande; S R Hann; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.